Sujal M. Patel, CEO, President, and Secretary, 10% Owner at Nautilus Biotechnology, Inc. (NAUT), bought 25,000 shares at $2.61 ($65K) on 2026-03-04, disclosed to the SEC on 2026-03-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| NAUT | BUY | 2024-03-11 | $41K | — | Filing → |
| NAUT | BUY | 2024-03-07 | $154K | — | Filing → |
| NAUT | BUY | 2022-08-08 | $268K | — | Filing → |